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ABSTRACT 
 
 
Background: Gestational diabetes mellitus (GDM) is a prevalent and growing epidemic 
that affected 8.2% of births in 2016 in the United States. Previous studies have shown 
that low magnesium (Mg) is associated with type II diabetes (T2DM), and the 
pathophysiology of GDM and T2DM is similar.  
Objective: To determine if low total Mg intake is associated with the risk of having 
GDM.  
Design: We did a cross-sectional secondary data analysis using data from the 2005-2007 
Infant Feeding Practices Study II which used a validated diet history questionnaire to 
collect dietary data. We analyzed total Mg intake from 1217 pregnant women in their 
third trimester and ran unadjusted and adjusted logistic regression models. Adjusted 
models included age, pre-pregnancy BMI, family history of T2DM, energy intake from 
food, and smoking as covariates.  
Results: Mean total Mg intake was 332+138mg/day and 8.8% of women consumed a 
dietary supplement containing Mg. In the unadjusted model, risk of GDM was not higher 
with low total Mg intake (OR [95% CI]: 0.96 [0.61, 1.51]). Adjusting for all covariates 
did not change the association (1.06 [0.64, 1.76]).  
Conclusions: Total Mg intake was not significantly associated with a higher risk of 
developing GDM. While this study found no association, a study with a larger sample 
size and adequate power, using dietary intake to measure total Mg status may indicate 
more significant findings.   
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 2 
Introduction 
 
The prevalence of gestational diabetes mellitus (GDM) in the United States (US) 
reached 8.2% in 2016 (1) and globally impacts about 14% (18 million) of births each year 
(2–5). In the US in 2007, GDM-related health concerns cost an additional $3,305 per 
pregnancy, totaling $636 million in increased healthcare dollars (6). Gestational diabetes 
is traditionally identified between 24-28 weeks of gestation and is defined as a fasting 
blood glucose of >126 mg/dL or a 2 hour post prandial 75g oral glucose tolerance test 
(OGTT) value of over 200 mg/dL (2,7). Gestational diabetes can lead to adverse maternal 
and child health outcomes including increased risks at birth (e.g. high infant birthweight, 
macrosomia [a newborn with a birthweight >4000g larger than average], shoulder 
dystocia [when the neonate’s shoulders are stuck in the mother’s pelvis], cesarean section 
[c-section], and stillbirth) and increased risk for the child and mother to develop chronic 
diseases later in life (e.g. type II diabetes mellitus [T2DM], cardiovascular disease, and 
obesity) (3,4).  
Gestational diabetes and T2DM are diagnosed via the same tests and criteria, as 
the pathophysiology of the two are similar (8–10). Gestational diabetes and T2DM occur 
when the pancreas still synthesizes insulin but the insulin is not effective, which is known 
as insulin resistance (8,9). Research shows low Mg intake is related to the prevalence of 
T2DM due to its role in the secretion of insulin and activation of the insulin receptor, 
which initiates a cascade for glucose uptake by cells (11–14). A randomized control trial 
by Asemi et al. (15) supplemented Mg for women with GDM which led to improved 
metabolic outcomes including decreased insulin and fasted plasma glucose (15). Like 
many other studies (14,16–19), Asemi et al. (15) used serum Mg to identify blood Mg 
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concentrations and assess Mg status. However, using serum Mg as a biomarker is a poor 
indicator for Mg total body status and dietary intake, as overall body Mg can be low 
without it being reflected in the serum (20). Therefore, it is important to target total Mg 
intake, as no current research to our knowledge uses low total Mg intake (which includes 
dietary Mg intake and Mg intake from dietary supplements) as their indicator for Mg 
status while assessing the risk of having GDM (2,10,17,18). While there is sufficient 
evidence to support the relationship between low Mg and T2DM, more research needs to 
be done to explore the effects of low total Mg intake and GDM.  
This retrospective, cross-sectional, secondary data analysis uses the Infant 
Feeding Practices Study II (IFPS II) from 2005-2007 to identify whether a relationship 
between Mg intake and GDM exists. This research uses results from a dietary history 
questionnaire (DHQ) used in IFPS II study taken during the mothers’ third trimester.  
 
Methods 
Study Design 
We conducted a cross-sectional, secondary-data analysis using 2005-2007 IFPS II 
data collected by the Food and Drug Administration (FDA) and the Centers for Disease 
Control and Prevention (CDC) which was Institutional Review Board approved by 
the FDA’s Research Involving Human Subjects Committee and the US Office of 
Management and Budget (21,22). This study analyzed whether total Mg intake was 
significantly associated with self-reported GDM. We hypothesized low total Mg intake (< 
the recommended dietary allowance (RDA) during pregnancy, which is a 400mg/day for 
women 18 years old, 350mg/day for women 19-30 years old, and 360mg/day for women 
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over 30 years old (23)) would be significantly associated with a higher risk of self-
reported GDM (11). 
Study Population 
The IFPS II was a longitudinal study for which pregnant women were recruited 
and postnatal follow-up on the mother and child continued until the child was 6 years old 
(22). Participants were recruited from a nationally distributed consumer opinion panel of 
500,000 US households (22). In a survey that is annually collected from this consumer 
opinion panel, women who were pregnant with a singleton between the ages of 18-40 
years old were identified and sent prenatal questionnaires, of which 4902 responded 
(must reside in zip codes unaffected by the Gulf Coast hurricanes of 2005) (22). From 
this cohort, 1749 were 28-32 weeks gestation and were sent a modified Dietary History 
Questionnaire (DHQ) during May-August 2005, of which 1444 women completed and 
returned before their infants were born (Figure 1) (22). The DHQ was modified from a 
validated quantitative food frequency questionnaire developed by the National Cancer 
Institute to better suit a pregnant population (modifications include recall period as 1 
month instead of 1 year and questions were added about fish intake and dietary 
supplements) and included 149 questions (21,22). A more detailed explanation of the data 
collection methods can be found in a descriptive study by Fein et al. 2008 (22). 
Statistical Analysis 
Daily dietary Mg intake was calculated from the DHQ using Diet*Calc software, 
which estimates nutrient intake from the DHQ (24). Gestational diabetes was established 
in the prenatal survey in which participants answered “yes”, “no”, or “don’t know/not 
sure” to the question, “Have you had gestational diabetes with this pregnancy?” Those 
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who replied “don’t know/not sure” (n=141) to the question were excluded for analysis 
(Figure 1).  
Statistical Analysis System (SAS) 9.4 software (SAS 9.4, Cary, NC) was used for 
all statistical analyses. 
Logistic regression analysis was used to determine whether the risk of GDM 
prevalence differed between high (> RDA per age group) and low (< RDA per age group) 
total Mg intake. The statistically significant level was set at p≤0.05. 
Potential confounding variables were identified in the literature, and included age, 
education, pre-pregnancy body mass index (BMI), and family history of diabetes (25–
31). Age was included as older women are at a higher risk of developing GDM and 
decreased Mg intake (25,26). Education was considered as a confounding variable as less 
education is a risk factor for GDM and tend to have lower Mg intake (26,27). High pre-
pregnancy BMI and family history of diabetes are risk factors for GDM (4,28). 
Additionally, a high pre-pregnancy BMI and low Mg intake are inversely associated with 
overweight and obese pre-pregnancy (28,31,32). If potential confounding variables were 
significantly associated with risk of having GDM (p<0.05), then they were included in 
the adjusted model. Of these potential confounding variables, age, pre-pregnancy BMI (4 
categories), and family history of T2DM were included as covariates for adjusted model 
1. Adjusted model 2 also controlled for age and family history of T2DM, but here we 
dichotomized pre-pregnancy BMI (underweight/normal BMI <25 kg/m2 and 
overweight/obese BMI >25 kg/m2), and included energy intake from food (residuals), and 
smoking. 
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 Continuous variables (age and BMI) were examined for normality using a 
Kruskal Wallis test (p<0.05). Data distributions were examined for outliers outside of +/- 
3 standard deviations from the mean (n=18) (Figure 1).  
Effect size for high and low total Mg intake was calculated using this equation 
below  (33).  
 
 
With our sample of n=1217, we determined power at 0.107 and an effect size of 0.02 
using G*power 3.0 and the results from this equation (34).  
 
Results 
 
Of the 1749 women who were in their third trimester, 305 women were removed 
if they had a previous diagnosis of diabetes resulting in 1376 participants. Women who 
responded “don’t know/not sure” to the question “have you been diagnosed with GDM 
during this pregnancy?” (n=141), and if their total Mg intake was +/- 3 standard 
deviations from the media (n=18) were also excluded from this analysis, resulting in a 
total of 1217 women for this study (Figure 1). The average age of the women in this 
study cohort was 29.5+5.5 years old with the majority having some college education 
(36.9% some college, 37.2% college graduate). Of respondents, about 34.3% had a 
family history of T2DM and 45.2% reported normal pre-pregnancy BMI between 18.5-
24.9kg/m2, and 47.7% had a BMI over 25.0kg/m2 (23.3% overweight, 24.1% obese). The 
mean total Mg intake was 332+138mg/day. There was no statistical significance for the 
risk of developing GDM between the 25th percentile of total Mg intake at 230mg/day, and 
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the 75th percentile at 406mg/day (p=0.18). Dietary supplements were used by 8.8% of 
participants and the mean total Mg intake for participants who reported dietary 
supplement intake was 344+143mg/day, while those who did not consume a dietary 
supplement had a mean Mg intake of 331+137mg/day. In total, 7.2% of participants 
responded “yes” when asked if they have been diagnosed with GDM during this 
pregnancy.  
For the logistic regression, we identified total Mg intake as high (> RDA per age 
group) or low (< RDA per age group). Risk of having GDM was not significantly 
associated with low Mg intake in the unadjusted and adjusted models. In the unadjusted 
model, risk of having GDM was not higher with low total Mg intake (OR [95% CI]: 0.96 
[0.61, 1.51]), dietary intake (1.00 [0.62, 1.62]), or for those who did use dietary 
supplements (0.75 [0.21, 2.64]). Adjusted model 1 for covariates did not change the 
association for total Mg intake (0.97 [0.59,1.58]), dietary Mg intake (0.95 [0.56, 1.59]), 
or use of dietary supplements (1.22 [0.27, 5.41]) and risk of having GDM (Table 2). 
Adjusted model 2 also had minimal effect for total Mg intake (1.06 [0.64, 1.76]), dietary 
Mg intake (1.03 [0.60, 1.75]), or use of dietary supplements (1.13 [0.23, 5.25]) and risk 
of having GDM (Table 2). Adjusted model 1 controlled for the covariates age, family 
history of T2DM, and pre-pregnancy BMI (4 categories), all of which were still 
significantly associated with risk of having GDM. Adjusted model 2 also controlled for 
age and family history of T2DM, but here we dichotomized pre-pregnancy BMI and 
included energy intake from food (residuals), and smoking. Energy intake from food was 
significantly associated with Mg intake (r2=0.85), and smoking (0.45 [0.23, 0.84]) and 
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dichotomized BMI (0.40 [0.24, 0.67]) were significantly associated with risk of having 
GDM. 
 
Discussion 
 
In this secondary analysis of IFPS II study, total Mg intake was not significantly 
associated with the risk of having self-reported GDM for the adjusted and unadjusted 
models. The average total Mg intake was slightly below the recommended daily 
allowance (23) with a small percentage who consumed a dietary supplement. Differences 
in age, family history of T2DM, and pre-pregnancy BMI were considered significant, and 
used as covariates in the adjusted model.  
Several studies have analyzed whether there is a relationship between Mg and 
GDM prevalence. When comparing other studies to our research sample characteristics 
were similar, however, these studies used different methods for diagnosing high and low 
Mg and GDM. One study by Tasdemir et al. (35) looked at ionized and total body Mg 
with a smaller dataset (n=85) in non-GDM compared to GDM participants. They found 
low ionized Mg in patients with GDM, which helped lead us to our hypothesis that low 
Mg intake would be associated with GDM. However, our results did not show a 
significant association like Tasdemir et al. (35) which could be because ionized levels of 
Mg may not directly reflect Mg intake, whereas measuring dietary Mg does. The mean 
age between non GDM (26.8+6.6) and GDM groups (30.8+6) were similar to ours 
(28.9+5.5 and 31+5.4, respectively) and like our sample, age was statistically significant 
for reported GDM (35). Those in the GDM group also had a similar percentage for family 
history of T2DM (47.5%) as our study (52.9%) and were significantly associated with 
GDM (35).   
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Another group of researchers (15) investigated Mg supplementation on metabolic 
status and its effect on pregnancy outcomes. This study also used a smaller sample size 
(n=70) compared to ours (n=1217) with a similar mean age of 29.3+3.9 (15). The results 
showed Mg supplementation was associated with decreased serum insulin and fasting 
plasma glucose, but like our results, did not find any direct association with GDM (15).  
A randomized control trial conducted by Zarean and Tarjan 2017 (36) used a 
sample of 180 pregnant women and compared 3 groups of 60 participants with Mg 
supplementation (group 1: control group with serum Mg >1.9 mg/dL; group 2: serum Mg 
levels <1.9 mg/dL and given a multimineral tablet; group 3: serum Mg levels <1.9 mg/dL 
given a Mg supplement). This study also used serum Mg as its Mg status marker. The 
results showed those who received a Mg supplement were less likely to develop GDM, 
which is inconsistent with our results. These results could be different from ours as serum 
Mg is not a valid marker of total Mg intake (20). 
The physiological mechanism of insulin resistance between T2DM and GDM is 
similar, and low Mg intake has shown to impact development of T2DM (4). The studies 
that investigated low serum Mg and GDM prevalence showed an inverse relationship 
between the two variables, while supplementing with Mg decreased GDM prevalence 
(15,35,36). However, our results did not show a significant association between low total 
Mg intake and risk of having GDM.  
Our findings may have differed from previous research for a number of reasons. 
First being the risk of having GDM in the IFPS II dataset was self-reported, and therefore 
likely under-reported. A study done in New Zealand by Lawrence et al.(37) found one 
third of medically diagnosed GDM went unreported in a questionnaire. Additionally, our 
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study used Mg intake from a DHQ, while these studies used serum Mg or experimented 
with the effect of Mg supplements on GDM outcomes. Though there were other studies 
that also did not have significant findings (30,38), there were none that specifically 
analyzed total Mg intake compared to risk of having GDM in the US.  
Our study has strengths and limitations that are worth reporting. The sample size 
is considered large (n=1217) when compared to other studies (15,35,36). However, we 
were unable to determine significant association between total Mg intake and risk of 
having GDM, which could be due to having low power. Our power was likely low 
because of the low amount of GDM diagnoses in this cohort (n=87, 7.2%). In order to 
increase power to 80%, we would need a sample size n=19,623 for an effect size of 0.08 
which would allow for a larger cohort with reported GDM. The DHQ used by IFPS II 
was derived from the NCI by the FDA and CDC and was previously validated (22). A 
limitation of this study is the cross-sectional design, as it does not allow for the 
determination of a temporal relationship or causality between Mg intake and GDM onset. 
Additionally, the DHQ did not differentiate whether the multivitamins or prenatal 
vitamins the participants may be taking contained Mg, which could have affected total 
and dietary supplemental intake. However, prenatal vitamins typically do not contain Mg 
or if they do, they only contain about 150mg on average (about 40% of RDA during 
pregnancy) (39,40). There is also a possibility that participants had undiagnosed pre-
existing type 1 or T2DM before this pregnancy, which could have interfered with the 
validity of GDM diagnosis. Additionally, in the past there was not a standardized 
diagnosis of GDM which could have an effect on true GDM diagnoses (4). It is also 
possible there were some confounding variables that we did not recognize and are not 
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adjusting for or were not included in the data. Though the study cohort collected in the 
IFPS II dataset was nationally distributed, it may not represent the whole US population 
(22). This is because the IFPS II data collection method used a self-selected consumer 
panel and not a random sample due to the cost of recruiting women in their third 
trimester, which may contribute to volunteer bias (22). Another limiting factor of this 
study is the use self-reported data from the prenatal questionnaire and DHQ, which may 
lead to response bias (22). However, DHQs are commonly used to asses total intake as 
they are easy to administer, noninvasive, inexpensive and currently the best method to 
measure Mg intake (41).  
In conclusion, this secondary-data analysis revealed no significant association 
between total Mg intake and GDM. Contrary to other markers of Mg status or studies 
using interventions with Mg supplements, this research used dietary and dietary 
supplement intake to determine if there was an association which is currently the most 
accurate measure of Mg intake. Though it could not be proved with this study, it is still 
possible there is an association between low Mg intake and risk of having GDM. The low 
power for this sample may have contributed to the insignificant results, as only a small 
fraction of women reported having GDM. With a larger sample size, 80% power could be 
reached with an effect size of 0.08 so that significant differences could be detected if 
present. This research was an important foundational step to further this investigation of 
the relationship of total Mg intake and GDM, as it uses dietary intake to measure 
micronutrient status in relation to incidence of disease which may give reason for further 
exploration.  
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Figures and Tables 
 
Figure 1: Flow chart of inclusion criteria for women in the Infant Feeding Practices 
Study II who provided diet history and GDM status used in this study.  
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Table 1: Maternal descriptive characteristics of the subsample population of 1217 
women in the Infant Feeding Practices Study II who provided diet history and GDM 
status.  
Maternal Characteristic Total 
n=1217 (%) 
Yes GDMa 
n=87 (7.1%) 
No GDM 
n=1130 (92.9%) 
P-value 
 
Education* 
   High school or less 
   Some college 
   College graduate 
   No response 
 
229 (18.8%) 
449 (36.9%) 
453 (37.2%) 
86 (7.1%) 
 
16 (18.4%) 
28 (32.2%) 
37 (42.5%) 
6 (6.9%) 
 
213 (18.8%) 
421 (37.3%) 
416 (36.8%) 
80 (7.1%) 
0.53 
Age, years 28.9 + 5.5 31 + 5.4 28.8 + 5.4 0.0003 
Family history of 
diabetesb 
Type I*  
   Yes 
   No 
   No response 
Type 2* 
   Yes 
   No 
   No response 
 
 
55 (4.5%) 
992 (81.5%) 
170 (14.0%) 
 
418 (34.3%) 
678 (55.7%) 
121 (10.0%) 
 
 
4 (4.6%) 
68 (78.2%) 
15 (17.2%) 
 
46 (52.9%) 
33 (37.9%) 
8 (9.2%) 
 
 
51 (4.5%) 
924 (81.8%) 
155 (13.7%) 
 
372 (32.9%) 
645 (57.1%) 
113 (10.0%) 
 
 
 
0.91 
 
 
0.0001 
 
 
Pre-pregnancy BMIc* 
   Underweightd 
   Normal weight 
   Overweight 
   Obese 
   No response 
 
67 (5.6%) 
550 (45.2%) 
288 (23.6%) 
294 (24.1%) 
18 (1.5%) 
 
1 (1.2%) 
25 (28.7%) 
23 (26.4%) 
36 (41.4%) 
2 (2.3%) 
 
66 (5.8%) 
525 (46.5%) 
265 (23.5%) 
258 (22.8%) 
16 (1.4%) 
0.0001 
Mean total Mge intake 
(mg/d) 
332 + 138 345 + 134 331 + 138 0.56 
Mean dietary Mg intake 
(mg/d) 
331 + 137 335 + 130 330 + 138 0.58 
Mean Mg intake with Mg 
supplement use (mg/d) 
344 + 143 346 + 168 344 + 141 0.45 
Mg supplement 
   Yes 
   No 
 
107 (8.8%) 
1170 (96.1%) 
 
11 (12.6%) 
76 (87.4%) 
 
96 (8.5%) 
1034 (91.5%) 
0.19 
aGestational diabetes mellitus  
bMaternal siblings, aunts/uncles, or parents 
cBody Mass Index 
dUnderweight <18.5 kg/m2, Normal weight = BMI 18.5-24.9 kg/m2, Overweight = BMI 
25-29.9 kg/m2, Obese = BMI >30 kg/m2 
eTotal maternal magnesium intake calculated from DHQ responses using Diet*Calc 
software 
*Missing data: education (n=131); type 1 diabetes (n=215); type 2 diabetes (n=166); BMI 
(n=63) 
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Table 2: Unadjusted and adjusted odds ratios (95% CI) from models examining 
Mga intake status by GDMb prevalence from participants in the Infant Feeding 
Practices Study II who completed the prenatal diet history questionnaire. 
Mg intake  
Yes GDM 
n=87 (7.2%) 
Unadjusted 
n=1217 
Adjusted (1)c 
n=1172 
Adjusted (2)d 
n=1072 
Total Mg intake  
(n=1217) 
 < RDAe (n=766) 
 > RDA (n=451) 
 
 
54 (7.1%) 
33 (7.3%) 
0.96 (0.61, 1.51) 
- 
0.97 (0.59, 1.58) 
- 
 
1.06 (0.64, 1.76) 
- 
Dietary Mg intakeh 
(n=1110) 
  < RDA (n=701) 
  > RDA (n=409) 
48 (6.9%) 
28 (6.9%) 
1.00 (0.62, 1.62) 
- 
0.95 (0.56, 1.59) 
- 
 
1.03 (0.60, 1.75) 
- 
Dietary supplement  
(n=107) 
   < RDA (n=65) 
   > RDA (n=42) 
 
6 (9.2%) 
5 (11.9%) 
 
0.75 (0.21, 2.64) 
- 
 
1.22 (0.27, 5.41) 
- 
 
 
1.13 (0.23, 5.25) 
- 
aMagnesium 
bGestational diabetes mellitus 
cAdjusted for age, family history of type II diabetes, and pre-pregnancy BMI (<18.5 
kg/m2, normal weight = BMI 18.5-24.9 kg/m2, overweight = BMI 25-29.9 kg/m2, obese = 
BMI >30 kg/m2) 
eTotal maternal magnesium intake calculated); missing n=138 due to no response from 
covariates 
dAdjusted for age, family history of type II diabetes, pre-pregnancy BMI (2 categories: 
underweight/normal BMI <25 kg/m2 and overweight/obese BMI >25 kg/m2), energy 
intake from food (residuals), and smoking; missing n=145 due to no response from 
covariates 
eRecommended daily allowance for Mg during pregnancy; 18 years old = 400 mg/day, 
19-30 years old = 350 mg/day, and over 30 years old = 360 mg/day 
hMissing data from those who consumed dietary supplement (n=107) 
iMissing data from those who did not consume dietary supplement (n=1110) 
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APPENDIX A: EXTENDED LITERATURE REVIEW 
 
Chapter 1: Magnesium 
Background, Functions, and Distribution 
 Magnesium is the fourth most abundant cation in our body, and an essential 
mineral that has many physiological functions (18,42). It is a cofactor for over 600 
enzymatic reactions, it activates over 200 enzymes, and is involved in processes like 
protein synthesis, energy production, muscle function, blood glucose regulation, nerve 
function, blood pressure, oxidative phosphorylation, and glycolysis (12,43). It was first 
identified as an essential mineral in 1926 by J. Leroy, and in the 1950s clinical effects 
from Mg deficiency were recognized, giving rise to the many roles requiring Mg (42). As 
an essential mineral is defined as a mineral or nutrient that is necessary for our bodies but 
cannot synthesize (44). When Mg is deficient, there can be detrimental effects including 
muscular and neurological symptoms (including tetany, spasms, and tremoring), poor 
appetite, nausea, and vomiting, so it is important we meet our required needs (11,45). 
Serum Mg deficiency, or hypomagnesemia, is typically defined as serum Mg levels less 
than 0.7-0.75 mmol/L, 1.4mEq/L, or 1.7 mg/dl and is prevalent among both developed 
and developing countries (12,43,46). It is associated with hypocalcemia as well, and side 
effects include weakness, fatigue, muscle cramping, tetany, feeling numb, and seizures 
(46). 
Physiology  
Our bodies cannot physically store Mg, therefore we retain Mg to maintain 
homeostasis based on physiological needs (47). Healthy adults typically have about 24g 
of Mg in their body, which amounts to about 0.4g/kg, where about 60-65% resides in our 
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bones, 27% in our muscles, 6-7% in other cells, and less than 1% extracellularly in the 
serum (39,42,46,48,49). Serum Mg is found either bound to a protein (25% albumin, 8% 
globulins), in a chelated fraction (meaning bound to a molecule, 12%), or in an ionized 
state where it is metabolically available for physiological functions (55%) (12,46).  
Magnesium is an important cofactor for more than 600 enzymes, meaning Mg is 
required to be present and bound to the enzyme to catalyze the reaction (50,51). 
Additionally, Mg is an activator for over 200 enzymatic reactions which is a type of 
cofactor that enhances enzymatic activity (50,51). Without Mg, all of these enzymatic 
reactions like energy production, protein synthesis, and insulin activation would not be 
fulfilled (50).  
The balance of Mg distribution and metabolism can be impacted by a variety of 
hormones including the parathyroid hormone (PTH), antidiuretic hormone (ADH), 
calcitonin, catecholamines, and insulin (12,20). Many impact Mg balance by controlling 
level of Mg resorption in different parts of the kidneys (20,52–54). Parathyroid hormone 
and Mg have a multifaceted relationship, as PTH will increase Mg resorption in the distal 
convoluted tubule of the kidneys, while Mg may reduce secretion of parathyroid hormone 
when calcium levels are low (20,52). When Mg levels are low, PTH will also stimulate 
release of Mg from the bones and increase absorption in the small intestine (53). 
Impaired PTH secretion and/or function can lead to hypomagnesemia which may induce 
hypocalcemia, while elevated calcium levels can lead to decreased Mg resorption (52,54). 
Antidiuretic hormone (or vasopressin) also has an effect on homeostasis of Mg (20). 
Similarly to PTH, ADH will stimulate Mg resorption in the distal convoluted tubule (53). 
Calcitonin regulates calcium in addition to Mg, by stimulating resorption in the thick 
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ascending limb of the nephron loop (loop of Henle) of the kidney (53). Catecholamines 
(like epinephrine, norepinephrine, and dopamine) can impact the intracellular balance of 
ions, including Mg distribution (55). As catecholamines are released, extracellular fluid 
increases resulting in a lower serum Mg (56). Insulin and Mg have a complex 
relationship as they both impact each other. Insulin contributes to maintaining total body 
Mg status, while Mg levels impact insulin activation and release from the beta cells of the 
pancreas (12,14). Insulin can regulate Mg uptake, as it can reduce serum Mg causing 
cytosolic levels of Mg to increase (57). 
Dietary Sources, Requirements, and Intake 
Magnesium is found in a variety of foods including green leafy vegetables, 
legumes, nuts and seeds, whole grains, water (variable) and typically most high fiber and 
high phytate foods (23,43,49). Even though Mg is present in a variety of foods available 
in a Western diet, most adult Americans do not meet their daily requirements (49). Since 
the early 1900s, Americans are now consuming half of the Mg of what they used to, 
dropping from about 500mg/day to 250mg/day (49). This may be due in part to the 
typical, overly processed American western diet which has decreased Mg content of food 
by about 85% (49,58). Americans have increased processed food consumption, which can 
therefore affect American’s dietary Mg intake (49).  
For women of reproductive ages specifically, the recommended dietary allowance 
(RDA) are 400mg/day, 350mg/day, and 360mg/day for ages 14-18, 18-30, and 31-50 
years old, respectively (23). Magnesium needs increase during pregnancy by an 
additional 40mg/day due to the increased body mass (39). Magnesium toxicity is rare, 
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and has only occurred through consuming supplements with no reports of toxicity 
exclusively through dietary intake (11). 
The use of Mg dietary supplements can increase Mg intake. Magnesium 
supplements are typically in the form of Mg oxide, citrate, stearate, acetyl taurate, or 
chloride (43,58). Magnesium citrate and Mg oxide are most frequently prescribed when 
dietary supplementation is necessary (58). A study performed on rats showed the highest 
levels of blood Mg when being supplemented using Mg malate, suggesting Mg malate is 
absorbed the most effectively, followed by Mg acetyl taurate suggesting these forms of 
Mg are the most bioavailable (58). Prenatal vitamins are typically not a good source of 
Mg intake, as only about 20% of prenatal supplements contain Mg (40). When Mg is in a 
prenatal vitamin, on average contributes to 7.6% of the daily value required for 
pregnancy (40). Therefore, if a woman is taking a prenatal vitamin, they would not be 
able to meet their Mg needs with the prenatal vitamin alone. She would need to consume 
food containing Mg or a Mg supplement to ensure adequate dietary intake. Previous 
studies show the benefits of supplementing Mg to reduce the risk of chronic diseases like 
T2DM, vitamin D deficiency, poor pregnancy outcomes (12,19,59).   
Absorption 
Only about 30-40% of dietary Mg intake is actually absorbed, but absorption can 
range from 25% when consuming high amounts of Mg to 75% when consuming 
inadequate amounts of Mg (20,46). Magnesium is absorbed as a free, unbound ion, Mg2+ 
and is absorbed best at a lower pH (47,60). It is absorbed passively primarily in the 
jejunum and ileum of the small intestine, and less absorption occurs in the colon (12,20). 
Absorption and retention of Mg is not affected by whether an individual has T2DM, 
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however, gastrointestinal diseases such as celiac disease, inflammatory bowel syndrome, 
and short bowel syndrome can have malabsorptive effects (12,47). Magnesium is 
excreted through bile and urine, and resorption occurs in the kidneys (12,20,47). 
The highly processed foods within the American western diet typically contain 
phosphate additives (found in foods like processed meats and sugar sweetened beverages) 
and low calcium intake, which can increase the required amount of Mg in order to remain 
in a positive balance (49). On the other hand, excess amounts of calcium and vitamin D 
can also increase Mg needs (49). Fiber, free fatty acids, oxalate, phytate, and high levels 
of phosphorus, iron, copper, manganese, and zinc can inhibit Mg absorption as well 
(47,61). However, many studies that investigated these relationships were using 
physiologically improbable amounts of the minerals (47). Magnesium is found in many 
foods containing phytates, and many believe that phytates found in foods will lower Mg 
absorption and lead to Mg deficiency (49). However, resorption of Mg in the kidneys will 
decrease the amount lost in the urine to make up for the Mg bound to the phytates being 
excreted (49). Oxalic acid which is also found foods like spinach, cabbage, and brussels 
sprouts, can also inhibit absorption of Mg by binding to it thus decreasing its ability to 
absorb as a free ion (47). Aluminum consumption is another factor that can inhibit Mg 
absorption thus increasing dietary needs, as aluminum is used in a variety of cookware, 
packaging, and topical products (49). 
 Since Mg is typically consumed as a whole food complex and not as an isolated 
form, many studies have researched the impact macronutrients and other food 
components has on Mg absorption (47,62–66). A high protein has shown to improve Mg 
absorption when compared to lower protein intake due to its effect on preventing Mg and 
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calcium complexes from forming, which would decrease absorption (47,62–66). The type 
of lipids consumed can also have an effect on Mg absorption in the gastrointestinal tract, 
as medium chain triglycerides increase absorption compared to long chain triglycerides 
(47). Additionally, low soluble and insoluble fibers can impact Mg absorption in the large 
intestine (47,67). This is due to the fermentation that occurs in the colon which results in 
a decreased, more acidic pH, thus improving Mg absorption (47,67). Lastly, it is possible 
that lactose can enhance Mg absorption, as it has been shown in rats but there has been 
conflicting evidence for the effect on humans (47,68). 
Magnesium Regulation 
Serum Mg can vary throughout the day due to our body’s regulatory mechanisms 
(60). Our bones and muscles have a mechanism that releases Mg into the serum to remain 
in homeostasis when Mg levels drop, therefore maintaining relatively constant serum Mg 
status (12,39). Continuous reduced Mg intake leads to Mg depletion, causing the bone to 
release Mg to maintaining Mg balance, which can negatively affect bone strength and 
contribute to bone-related deficiencies and diseases (46).  
In addition to bones, the kidneys also help to regulate serum Mg homeostasis via 
renal resorption (20,46). About 96% of Mg is reabsorbed in the kidneys using active 
transport, thus requiring energy (46,47). This resorption occurs in the nephron of the 
kidney, and occurs to maintain balance of minerals (46). Ten to 30% of the Mg is 
reabsorbed in the proximal convoluted tubule using a sodium gradient, 40-70% 
reabsorbed in the thick ascending limb using cotransport and an electrochemical gradient, 
and 5-10% through the distal convoluted tubule using active transport (46).   
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Magnesium Status Measurements 
The most common clinical diagnosis of hypomagnesemia uses serum Mg, but it is 
a poor indication of Mg intake or total body status (20). Total body depletion of Mg can 
be overlooked by a serum Mg reading, as serum Mg is a poor indicator of total body Mg 
and dietary intake due to the body’s ability to regulate serum levels (20,46) Therefore, 
hypomagnesemia is commonly undiagnosed (20). One reason may be attributed to the 
homeostasis mechanisms of our bones and kidneys (12,20,39,46). Additionally, serum 
Mg measurements include protein-bound Mg, and therefore changes in serum protein 
concentrations may affect serum Mg measurements (20).  
Magnesium status is also measured using ionized Mg, which may be a better 
indicator for total body Mg than serum Mg (69). Ionized Mg represents the most 
biologically available, unbound form of Mg and represents about 55% of Mg in the body 
(35,69). Therefore, changes in proteins that may be bound to Mg will not affect ionized 
Mg readings (20). However, the methodology of obtained ionized Mg still needs to be 
researched to ensure accuracy, as it requires an ultrafilterable Mg and is not routinely 
used (20,70). Obtaining ionized Mg is an invasive and complicated method to attain Mg 
status, as it requires blood draw and further testing afterwards (20,70). There is no 
documented method to accurately measure Mg status (70).  
 Measuring dietary intake using a food frequency questionnaire (FFQ) is the 
preferred method to obtain Mg status (43). Diet*Calc software can be used to import the 
nutrients into a Diet*Calc food database so they can then be analyzed (24). Diet*Calc can 
be edited if a FFQ is modified (24). 
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Magnesium and Diabetes 
 Due to its integral role in insulin activation and insulin release from the beta cells 
of the pancreas, many studies show low Mg is strongly linked to development of T2DM 
(13,14,71). A study by Mckeown et al.(13) reported high dietary and supplemental Mg 
intake can reduce the risk of impaired glucose tolerance and metabolism in adults by 
37%. Another study found that hypomagnesemia (total serum Mg below 1.7mg/dL) was 
associated with T2DM due to its role with tyrosine kinase (TK) and activation of the 
insulin receptor (71,72). Based on previous research that shows low serum Mg is 
associated with T2DM onset, Pokharela et al. (71) evaluated the relationship between 
hypomagnesemia and T2DM in a Nepalese population sample using a case-control 
experimental design and found that hypomagnesemia was present in half of the 
participants with diabetes (71). Furthermore, low serum Mg was associated with insulin 
resistance and diabetes-related complications such as dyslipidemia, poor glycemic 
control, and renal insufficiency (71). The research by Pokharela et al.(71) indicates that 
low serum Mg is associated with insulin resistance, which creates the need to discuss the 
physiologic relationship between Mg and insulin.  
 Magnesium affects insulin activity in two major ways: 1) insulin secretion from 
the beta cells of the pancreas, and 2) activation of the insulin receptor (14,15). When Mg 
levels are inadequate, it can inhibit the beta cells of the pancreas to release insulin 
causing pancreatic beta cell dysfunction (14). Magnesium levels affect insulin secretion 
in two ways, as there are two major steps involved in insulin secretion (14). First, Mg can 
impact the phosphorylation by glucokinase after glucose entering the cell, as glucokinase 
activity directly depends on a Mg-adenosine triphosphate (ATP) complex (14). Therefore 
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when Mg levels are low, the cell cannot successfully entrap glucose by phosphorylation 
(14). In a normal healthy adult, the beta cells use changes in membrane potential to react 
to glucose in the blood and secrete insulin (14). This membrane potential can become 
disrupted when a potassium channel becomes blocked causing membrane depolarization 
(14). Magnesium’s role in this second step is to activate and open the potassium channel 
which will stimulate the release of insulin (14). 
The second major way Mg can impact insulin is through insulin receptor 
activation (48). Insulin activation begins with binding of insulin to the alpha subunit of its 
TK insulin receptor resulting in phosphorylation of the TK subunit (14). Magnesium is 
the main cofactor for the phosphorylating TK (69). More specifically, free intracellular 
Mg will bind to the phosphate groups on ATP to form a Mg-ATP complex (12,51). When 
Mg is attached to ATP, it improves the binding ability of ATP to active sites of protein 
kinases including TK (51,69,73). Once TK is phosphorylated and activated, it can 
subsequently initiate the effects of insulin activity, creating a cascade of reactions to 
bring glucose into cells for use or storage (13,72,74). Gestational diabetes is typically 
attributed to a combination of pancreatic beta-cell dysfunction and insulin resistance 
which can be caused by reduced TK phosphorylation (4). Therefore, when there is low 
intracellular Mg, TK cannot auto-phosphorylate as efficiently which results in disordered 
TK activity, thus insulin resistance (69).  
A study done by Tasdemir, et al.(35) compared the ionized unbound Mg and total 
body Mg levels in women with and without GDM using in 85 pregnant women, of which 
40 of were diagnosed with GDM. Tasdemir, et al.(35) hypothesized low Mg would be 
associated with insulin resistance during pregnancy based on previous research showing 
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an association between hypomagnesemia and impaired glucose. The results showed a 
relationship between low total Mg and low ionized Mg and development of GDM, thus 
suggesting Mg is a crucial ion in the development of GDM (35). Given that the 
pathophysiologic mechanism for both T2DM and GDM are the same in that both observe 
insulin resistance, it is critical to investigate how supplemental and dietary intake of Mg 
may be associated with GDM (10). 
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Chapter 2: Gestational Diabetes 
Background, Prevalence, and Cost of GDM 
Gestational diabetes is defined as glucose intolerance that is first recognized while 
pregnant, and is typically diagnosed between 24-28 weeks gestation without any prior 
diagnosis of type 1 or T2DM (4,7,75). Glucose intolerance is defined as a fasting blood 
glucose of >126 mg/dL or a 2 hour post prandial 75g oral glucose tolerance test (OGTT) 
value of over 200 mg/dL (2,7). Historically, GDM diagnosis was not always 
standardized, and therefore many cases may have gone undiagnosed (4). Undiagnosed 
and therefore untreated GDM can have continuous risks of morbidity and mortality for 
the mother and the baby (76). Screening, diagnosing, and treating cases of GDM is 
important for maternal and fetal health outcomes during and after pregnancy, as well as 
healthcare spending (6,77). 
Gestational diabetes is also quite costly. In the US in 2007, GDM-related 
diagnoses cost an additional $3,305 per pregnancy, totaling $636 million in increased 
healthcare dollars (6). About 50% of GDM typically subsides postpartum, which means 
50% continues on to T2DM contributing to the $327 billion spent on T2DM in 2017 
(2,4,5,78). Gestational diabetes was estimated affect 1-14% (1 in 7) of pregnancies 
globally in 2017 (10,79) and represented 83-87.5% of all diabetic pregnancies globally 
(75). This prevalence marks GDM the most common condition women develop during 
pregnancy and diagnoses continue to increase worldwide (2,3). The suspected increase in 
GDM development may be due to the rise in obesity, reduction in physical activity, and 
increase in maternal age (10). It is recommended to complete screenings earlier in 
pregnancy (meaning at the beginning of the first trimester and/or when antenatal care 
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begins) for women who may have these risk factors so that non-GDM diabetes can be 
diagnosed if present, and therefore GDM is not being mistaken for pre-existing diabetes 
(10). To date, there is still no standard method of diagnosing GDM during an early 
pregnancy screening and it is still controversial, as physicians may use fasting plasma 
glucose, random plasma glucose, HbA1C, or 75g 2 hour OGTT (10). Gestational diabetes 
is typically diagnosed in a screening later in pregnancy during the third trimester (10). 
Risk Factors & Adverse Outcomes of GDM 
 There are many factors that may increase the risk of developing GDM. Common 
risks include pre-pregnancy overweight or obesity, gestational weight gain, central 
adiposity, hypertension or preeclampsia during pregnancy, western diet patterns, 
micronutrient deficiencies (e.g. vitamins B2, B6, B12, and folic acid which are vital in 
homocysteine homeostasis), maternal age >35 years old, and family history of diabetes 
(4,25,80). The risk of developing GDM increases as BMI increases, where a study 
showed it was 2.14 times higher in pregnant women who are overweight (BMI 25.0-
29.9kg/m2), 3.56 times higher in pregnant women who are obese (BMI 30.0-34.9kg/m2), 
and 8.56 times higher in very obese pregnant women (BMI >35.0kg/m2) when compared 
to pregnant women with a normal BMI (BMI 18.5-24.9kg/m2) (81). 
 Gestational diabetes can lead to adverse maternal and fetal outcomes and has been 
studied extensively. The Hyperglycemic and Adverse Pregnancy (HAPO) Study looked 
at adverse pregnancy outcomes in pregnant women with obesity and GDM (82). This 
research showed that GDM and obesity are both independently associated with adverse 
pregnancy and birth outcomes, but together have an even stronger association with each 
outcome analyzed (82). Catalano et al.(82) used an OGTT to diagnose GDM which 
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showed women with GDM had a higher prevalence of higher birthweight, newborn body 
fat percent, c-section, and preeclampsia than women without GDM (82). An increase in 
fetal adiposity can develop with maternal hyperglycemia which can be a contributing risk 
factor for chronic diseases like cardiovascular disease and T2DM for the offspring later 
in life (82,83). Other common fetal consequences from maternal GDM that are increased 
when GDM is not recognized are macrosomia, large for gestational age, shoulder 
dystocia, and other kinds of birth trauma (76,84). A prospective 4-year cohort study by 
Yang et al.(3) found GDM prevalence was associated with high birth weight, as well as 
an increased risk for large for gestational age and macrosomia. Fetal macrosomia occurs 
in about 15-45% of babies born to mothers with diabetes which is 3 times more than 
mothers with normal blood glucose levels (85,86). This is due to a modification in lipid 
metabolism from maternal hyperinsulinemia which can occur as a response to 
hyperglycemia, resulting in increased protein and fat storage of the fetus (3,85,86). 
Hyperinsulinemia occurs when the beta cells of the pancreas overproduce insulin in 
response to continued elevated blood glucose levels from resistant insulin (87). A study 
by Ogonowski et al.(85) showed the rate of macrosomia and large for gestational age is 
decreased when maternal hyperglycemia is treated and controlled. This supports the need 
to screen for GDM so it can be properly treated to avoid adverse fetal outcomes (85).  
 Development of GDM can also lead to unfavorable maternal short and long term 
outcomes (75,88). The most common potential risks of developing GDM for mothers 
include c-section delivery, pre-eclampsia or pregnancy-induced hypertension, weight 
gain, increased triacylglycerol blood concentrations, decreased high-density lipoproteins, 
decreased insulin sensitivity post-partum and/or development of T2DM (60% of women 
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with GDM develop T2DM later in life), antenatal depression, and increased maternal 
adipose tissue (75,88–90). These studies, among many others (3,4,10,79), indicate that 
GDM can lead to unfavorable birth outcomes and development of chronic diseases for 
the mother and child, thus providing a strong foundation as to why it is important to 
examine strategies to decrease GDM prevalence. 
Mechanism of Insulin in GDM 
Insulin is made in the beta cells of the pancreas. When blood glucose levels are 
elevated, insulin is released in response to a change in membrane potential (10,14,87). 
Insulin acts by signaling the insulin-dependent GLUT transporter proteins by binding to 
their membrane receptors on the apical membrane of cells when glucose is elevated to 
transport glucose out of the blood and into the cell (45).The mechanism of GDM is 
similar to T2DM, where the beta cells do not release insulin in response to the elevated 
glucose levels, or the insulin that is released is  is impaired and does not stimulate the 
GLUT transporter proteins in reaction to the stimulation of elevated blood glucose levels, 
and therefore does not facilitate glucose uptake into cells (87,88). Specifically, the 
translocation of GLUT4 that is normally stimulated by insulin to increase glucose uptake 
is impaired (7). This can lead to hyperglycemia, potentially hyperinsulinemia, as insulin 
initiates uptake of glucose by cells in the fed state (45). Gestational diabetes can occur 
when a mother is hyperglycemic due to these pathophysiological mechanisms of insulin 
(88). 
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